Diverse Clinical and Molecular Characteristics of Advanced POLE-Mutated Endometrial Carcinoma: Emphasis on Aggressive Variants and Co-Occurring Mutations - Top-Institutions - MDSpire

Diverse Clinical and Molecular Characteristics of Advanced POLE-Mutated Endometrial Carcinoma: Emphasis on Aggressive Variants and Co-Occurring Mutations

  • By

  • Nicolo Cavasin

  • Sami Kilzie

  • Mattia Vinci

  • Rita Trozzi

  • Camilla Nero

  • Stefano Restaino

  • Chiara Cassani

  • Sandro Pignata

  • Carmela Pisano

  • Giuseppe Scibilia

  • Robert Fruscio

  • Rosanna Mancari

  • Adolfo Favaretto

  • Matteo Fassan

  • Luisa Toffolatti

  • Giovanna Gallina

  • Francesco Fanfani

  • Vanda Salutari

  • Grazia Artioli

  • April 29, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Gynecologic Oncology
    • Molecular Pathology
    • Cancer Genomics

  • #2

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Gynecologic Oncology
    • Cancer Genomics
    • Translational Medicine

  • #3

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Gynecologic Oncology
    • Molecular Pathology
    • Clinical Trials

  • #4

    University of California, San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center
    University of California, San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center

    San Francisco, CA

    Key Differentiators

    • Gynecologic Oncology
    • Cancer Genomics
    • Precision Medicine

  • #5

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Gynecologic Oncology
    • Molecular Pathology
    • Cancer Biology

Original Source(s)

Diverse Clinical and Molecular Characteristics of Advanced POLE-Mutated Endometrial Carcinoma: Emphasis on Aggressive Variants and Co-Occurring Mutations

  • by Nicolo Cavasin, Sami Kilzie, Mattia Vinci, Rita Trozzi, Camilla Nero, Stefano Restaino, Chiara Cassani, Sandro Pignata, Carmela Pisano, Giuseppe Scibilia, Robert Fruscio, Rosanna Mancari, Adolfo Favaretto, Matteo Fassan, Luisa Toffolatti, Giovanna Gallina, Francesco Fanfani, Vanda Salutari, Grazia Artioli

  • April 29, 2026

Related Content

Is full adherence mandatory? Real-world outcomes of completing perioperative chemoimmunotherapy in resectable non-small cell lung cancer

Stimuli-responsive nanoplatforms for sonodynamic immunotherapy: opportunities and challenges in cancer treatment

Validation of a cervical CDO1/CELF4 methylation test for endometrial cancer: a prospective paired-sample comparison with intrauterine specimen